Inspiratory Flow Rates Achieved by the COPD Patients Through Breezhaler®, Ellipta® and Handihaler® Inhaler Devices

NCT02596009 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

97

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Disease, Chronic Obstructive (COPD)

Interventions

DEVICE: Breezhaler®
DEVICE: Ellipta®
DEVICE: Handihaler®

Sponsor

Novartis Pharmaceuticals